Episode Details

This story was originally published on HackerNoon at: https://hackernoon.com/anterra-capital-reaches-$100m-first-close-for-fund-iii-to-back-ai-in-the-$10t-food-industry.
Anterra Capital reaches a $100M first close on Fund III, targeting $200M, backing AI-native biotech and software in food and agriculture at the cycle's bottom.
Check more stories related to undefined at: https://hackernoon.com/c/undefined. You can also check exclusive content about #anterra-capital, #funding, #startup, #biotechnology, #artificial-intelligence, #farming, #agritech, #good-company, and more.

This story was written by: @ishanpandey. Learn more about this writer by checking @ishanpandey's about page, and for more stories, please visit hackernoon.com.

Anterra Capital announced a $100 million first close on Fund III in June 2026, targeting $200 million, with backing from Rabobank, Novo Holdings, and Zoetis among others. Anterra Capital is a specialist food and agriculture venture firm founded in Amsterdam in 2013, with offices in Amsterdam and Boston, managing over $500 million across three funds. Anterra builds companies from scratch in addition to backing them; its company creation Invetx was founded in 2018 and sold to Dechra Pharmaceuticals for up to $520 million within six years. Anterra's company creation Enko Chem, founded in 2017, develops new crop protection chemistry to replace glyphosate, with research partnerships with Bayer and Syngenta. Global agrifoodtech venture funding peaked at $51.7 billion in 2021 before falling to roughly $16 billion by 2025, a reset to 2016 levels that Anterra calls the most attractive entry point in twelve years. Fund III's first two investments are Anchr, an AI-native food distribution platform backed alongside a16z Speedrun, and Animerra, a veterinary biologics company Anterra founded and built in-house. Anterra operates with 11 full-time employees and 4 partners, relying on a venture-partner and LP network rather than headcount to extend its reach.